Mingkun Zhao†, Guanghui Zhu†, Aobo Zhuang†, Hanxing Tong, Yuan Fang*, and Yong Zhang*
Zhao et al, J Clin Transl Res 2022; 8(5):1
Published online: August 12, 2022
†These authors have contributed equally to this work
Abstract
Background: There are lacking standard treatment guidelines for aggressive fibromatosis (AF) because of its rarity.
Aim: This study aimed to investigate the risk factors for recurrence and survival of abdominal AF after radical surgical resection.
Methods: From August 2012 to December 2020, a retrospective analysis was conducted on the clinical data of 69 aggressive fibromatosis in Shanghai Public Health Clinical Center Affiliated to Fudan University, with the tumor locating either in the abdominal wall or in the abdominal cavity. The main observation endpoint were progression-free survival time (PFS) and overall survival time (OS).
Results: All 69 patients achieved microscopic R0 resection, 10 (14.5%) had local recurrence, and 3 (4.3%) died. The progression-free survival rate (PFS) after 1, 3, 5 and 10 years was 96.8%, 87.7%, 78.8% and 78.8%, respectively. The overall survival rate (OS) after 1, 3, 5 and 10 years was 100%, 100%, 92.9%, and 81.3%, respectively. In 10 patients with recurrence, the median recurrence time was 17.6 months. Concomitant familial adenomatous polyposis (FAP) and history of previous recurrence were independent risk factors of postoperative recurrence.
Conclusion: After radical surgery of abdominal AF, the local recurrence rate was 15%. Concomitant FAP and a previous history of recurrence were independent risk factors of postoperative recurrence. R0 and a combined organ resection should be performed especially in FAP patients to minimize the recurrence and improve the prognosis.
Relevance for patients: The current study identifies the risk factors of recurrence in AF and suggests R0 resection especially in concomitant FAP patients. A wait-and-see strategy should not be generally implemented
DOI: http://dx.doi.org/10.18053/jctres.08.202205.001
Author affiliation
1. Department of General Surgery, Shanghai Public Health Clinical Center, Fudan
University, Shanghai, China
2. Department of Gastrointestinal Surgery, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
3. Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
*Corresponding author
Yuan Fang
Department of General Surgery, Shanghai Public Health Clinical Center, Fudan
University, Shanghai, China
Email: fangyuan@shphc.org.cn
Yong Zhang
Department of General Surgery, Shanghai Public Health Clinical Center, Fudan
University, Shanghai, China
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Email: zhangyong1@zs-hospital.sh.cn
Handling editor:
Michal Heger
Department of Pharmaceutics, Utrecht University, the Netherlands
Department of Pharmaceutics, Jiaxing University Medical College, Zhejiang, China
Downloads
Full text PDF
Review process file (130.0 KB)
